Literature DB >> 22197622

Comparison of laparoscopy and laparotomy for endometrial cancer.

Hui Zhang1, Jing Cui, Lin Jia, Shuhui Hong, Beihua Kong, Dadong Li.   

Abstract

OBJECTIVE: To compare the safety and efficacy of laparoscopy and laparotomy on clinical outcomes among patients with endometrial cancer.
METHODS: Eligible randomized controlled trials (RCTs) conducted between 1966 and June 2010 were analyzed by meta-analysis.
RESULTS: Eight RCTs were included, with 3599 patients in total. No significant difference was observed between laparoscopy and laparotomy in overall (odds ratio [OR], 0.96; 95% confidence interval [CI], 0.50-1.82; P=0.892), disease-free (OR, 0.96; 95% CI, 0.50-1.82; P=0.892), or cancer-related (OR, 0.90; 95% CI, 0.27-3.08; P=0.871) survival. More intraoperative complications (OR, 1.33; 95% CI, 1.03-1.73; P=0.030), fewer postoperative complications (OR, 0.59; 95% CI, 0.46-0.75; P<0.001), longer operative time (standardized mean difference [SMD], 0.80; 95% CI, 0.46-1.15; P<0.001), lower blood loss (SMD, -2.29; 95% CI, -3.67 to -0.91; P=0.001), and shorter hospital stay (SMD, -2.60; 95% CI, -3.47 to -1.72; P<0.001) were associated with laparoscopy. There was no significant difference between the groups in pelvic (SMD, 0.22; 95% CI, -0.03 to 0.48; P=0.086) or para-aortic (SMD, 0.54; 95% CI, -0.04 to 1.11; P=0.067) lymph node yield.
CONCLUSION: Laparoscopy has short-term advantages and seemingly equivalent long-term outcomes and, in experienced hands, might be a feasible alternative to laparotomy for endometrial cancer.
Copyright © 2011 International Federation of Gynecology and Obstetrics. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197622     DOI: 10.1016/j.ijgo.2011.10.022

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Patient, surgeon, and hospital disparities associated with benign hysterectomy approach and perioperative complications.

Authors:  Ambar Mehta; Tim Xu; Susan Hutfless; Martin A Makary; Abdulrahman K Sinno; Edward J Tanner; Rebecca L Stone; Karen Wang; Amanda N Fader
Journal:  Am J Obstet Gynecol       Date:  2016-12-26       Impact factor: 8.661

2.  Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging.

Authors:  Yu Guo; Ping Wang; Penghui Wang; Wei Gao; Fenge Li; Xueling Yang; Hongyan Ni; Wen Shen; Zhi Guo
Journal:  Onco Targets Ther       Date:  2017-12-15       Impact factor: 4.147

3.  Laparoscopic versus Laparotomy: Staging Surgery for Endometrial Cancer - Malaysia's Early Experience.

Authors:  Wan Ahmad Hazim Wan Ghazali; Siti Amira Jamil; Ili Abdullah Sharin
Journal:  Gynecol Minim Invasive Ther       Date:  2019-01-23

4.  Laparoscopic surgery for low, intermediate and high-risk endometrial cancer.

Authors:  Mehmet Ali Vardar; Umran Kucukgoz Gulec; Ahmet Baris Guzel; Derya Gumurdulu; Ghanim Khatib; Gulsah Seydaoglu
Journal:  J Gynecol Oncol       Date:  2018-11-16       Impact factor: 4.401

5.  Clinicopathological features and prognostic factors for uterine myoma.

Authors:  Xiaoli Wu; Yanqing Zheng
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

6.  The retrograde and retroperitoneal totally laparoscopic hysterectomy for endometrial cancer.

Authors:  Eugenio Volpi; Luca Bernardini; Anna Maria Ferrero
Journal:  Int J Surg Oncol       Date:  2012-07-13

7.  Laparoscopy Versus Laparotomy in the Treatment of High-Risk Endometrial Cancer: A Propensity Score Matching Analysis.

Authors:  Huiqiao Gao; Zhenyu Zhang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  Does the Type of Surgical Approach and the Use of Uterine Manipulators Influence the Disease-Free Survival and Recurrence Rates in Early-Stage Endometrial Cancer?

Authors:  Josefa Marcos-Sanmartín; José Antonio López Fernández; José Sánchez-Payá; Óscar Cruz Piñero-Sánchez; María José Román-Sánchez; María Asunción Quijada-Cazorla; María Amparo Candela-Hidalgo; Juan Carlos Martínez-Escoriza
Journal:  Int J Gynecol Cancer       Date:  2016-11       Impact factor: 3.437

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.